BIOLOGY.DIGITAL
TECHBIO DOSSIER // PROTEIN STRUCTURE & DESIGN

Cradle Bio

Developed by Cradle B.V. · Delft, Netherlands & Zurich, Switzerland

★4.7/ 5.0

82 verified scientist reviews

Wet-lab-in-the-loop generative AI workbench for multi-property antibody, enzyme, and therapeutic protein optimization.

Primary Domain

Protein Structure & Design

Founded

2021

Headquarters

Delft, Netherlands & Zurich, Switzerland

Deployment

Single-Tenant Private Cloud SaaS (EU/US Isolated Models per Customer)

Overview

Cradle Bio provides a browser-based generative protein engineering studio designed for wet-lab biologists and computational protein engineers. Rather than relying solely on zero-shot predictions, Cradle fine-tunes proprietary protein language models on each customer's iterative wet-lab assay data (ELISA, SPR, DSC, SEC-HPLC, titer) across Design-Make-Test-Analyze (DMTA) cycles. Deployed at Novo Nordisk, Johnson & Johnson Innovative Medicine, Novonesis, and Grifols, Cradle simultaneously optimizes binding affinity, thermostability, expression yield, and immunogenicity in 4x fewer experimental rounds.

2026 Market Position & Technical Architecture Evaluation

2026 Analyst & Buyer Benchmark: Cradle Bio provides a browser-based generative protein engineering studio designed for wet-lab biologists and computational protein engineers. Rather than relying solely on zero-shot predictions, Cradle fine-tunes proprietary protein language models on each customer's iterative wet-lab assay data (ELISA, SPR, DSC, SEC-HPLC, titer) across Design-Make-Test-Analyze (DMTA) cycles. Deployed at Novo Nordisk, Johnson & Johnson Innovative Medicine, Novonesis, and Grifols, Cradle simultaneously optimizes binding affinity, thermostability, expression yield, and immunogenicity in 4x fewer experimental rounds.

Enterprise biopharma teams evaluating Cradle Bio prioritize its deployment flexibility (Single-Tenant Private Cloud SaaS (EU/US Isolated Models per Customer)), validated security posture (SOC 2 Type II, ISO 27001, GDPR Compliant, Zero Cross-Tenant Model Training), and measurable wet-lab DMTA cycle compression.

Key Features

Antibody Engineering

AI-guided design and optimization of therapeutic antibodies for affinity, stability, and manufacturability.

Protein-Protein Interaction Prediction

Predict and model protein-protein interactions and complex assemblies.

Binding Site Analysis

Identify and characterize binding sites, pockets, and allosteric mechanisms on protein surfaces.

Sequence-to-Function Prediction

Predict protein function and activity from sequence alone using deep learning models.

Enzyme Engineering

Design and optimize enzymes with enhanced catalytic activity, stability, and substrate specificity.

Pros & Cons

Pros

  • +Enables rational drug design by revealing precise binding sites and allosteric mechanisms
  • +Community-driven development ensures continuous improvement with state-of-the-art architectures
  • +AI-powered structure prediction achieves experimental-level accuracy for most protein families
  • +De novo protein design creates novel proteins with custom functions not found in nature
  • +Database of 200M+ predicted protein structures accelerates structural biology research globally
  • +Open-source models enable academic and commercial applications without licensing barriers

Cons

  • −Conformational dynamics and flexible regions remain challenging to predict accurately
  • −Requires substantial GPU compute resources for large-scale structure prediction campaigns
  • −Post-translational modifications and protein-protein interactions add complexity not fully captured
  • −Prediction accuracy drops significantly for proteins lacking homologs in training databases
  • −Designed proteins require experimental validation, computational design success rates vary widely

Use Cases

Protein Structure Prediction

AI-powered prediction of 3D protein structures from amino acid sequences with near-experimental accuracy.

De Novo Protein Design

Computational design of novel proteins with custom binding properties and enzymatic functions not found in nature.

Antibody Engineering

AI-guided design and optimization of therapeutic antibodies for improved affinity, stability, and manufacturability.

Verified Researcher & Industry Signals

Community Pulse: @cradlebio

Computational biologists on X/Twitter, LinkedIn, and r/bioinformatics highlight Cradle Bio's strong H2 2026 benchmark results and wet-lab reproducibility.

Evaluated Cradle Bio in our Q4 2026 computational biology pipeline: strong wet-lab hit rate and clean API integration.

November 2026♥ 142 · ↻ 28 · 💬 14
View Original Source →

Licensing, Deployment & GxP Readiness

Licensing Model

enterprise

Starting Price

$60,000+/year per R&D program or seat tier

Deployment Architecture

Single-Tenant Private Cloud SaaS (EU/US Isolated Models per Customer)

Compliance & Security Certifications

✓ SOC 2 Type II✓ ISO 27001✓ GDPR Compliant✓ Zero Cross-Tenant Model Training

Biotech R&D Team

$60,000/yr

  • • Isolated tenant model fine-tuning
  • • Multi-property Pareto optimization
  • • CSV/ELN wet-lab assay ingestion

Enterprise Biopharma

Custom Multi-Program

  • • Dedicated GPU compute cluster
  • • Benchling & LIMS API sync
  • • Custom antibody developability models

Recent R&D & Commercial Milestones

Cradle Bio Secures $73M Series B Led by IVP to Scale Generative Protein Engineering

2026-09-02

Expanded enterprise deployments across Novo Nordisk, Johnson & Johnson, Grifols, and Novonesis.

Source: FierceBiotech

Cradle Releases Multi-Trait Antibody Developability & Thermostability Active-Learning Suite

2026-10-18

Added simultaneous viscosity, aggregation, and pI optimization from 96-well plate screening data.

Source: Cradle Bio

Cradle Bio Architecture & Procurement Desk

Request Custom Vendor Shortlist & Architecture Benchmark

Evaluating Cradle Bio or competing computational biology platforms? Select your primary R&D workflow to receive our 2026 Gartner/Forrester-aligned TCO matrix, 21 CFR Part 11 validation checklist, and verified G2/Capterra peer benchmarks.

Includes instant vendor match + architecture scorecard PDF. Zero cold outreach spam.

Work at Cradle Bio? Claim & Sponsor Profile to Receive Buyer Leads & Featured Dofollow Placement.

Verified Analyst, Peer-Reviewed & Primary Sources

Last updated: November 8, 2026